Galera Therapeutics Inc (GRTX) Return on Investment ROI from the first quarter of 2026 to first quarter of 2025 and for the year 2026, average high and low, overall ranking from Mar 31 2026 to Mar 31 2025 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Galera Therapeutics Inc   (GRTX)


Galera Therapeutics Inc's ROI from its first quarter of 2026 to the first quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Galera Therapeutics Inc's ROI in the first quarter of 2026?
Galera Therapeutics Inc achieved a return on average invested assets (ROI) of 2637.52 % in its first quarter of 2026, this is above GRTX's average return on investment of 51.84%.
Galera Therapeutics Inc invested over the 12 months ending in its first quarter of 2026 $2 million

Despite the deterioration in its net income, company has improved ROI compared to the fourth quarter of 2025.

Within the Healthcare sector Galera Therapeutics Inc achieved the highest return on investment. While Return on investment, overall ranking has progressed in the Mar 31 2026 quarter, so far to 18, from total ROI ranking in the fourth quarter of 2025 at 19.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter
Y / Y Investment Change TTM -68.03 % -71.04 % -79.01 % -75.74 % -69.45 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 1 4 2 3 4
Return On Investment (TTM) 2637.52 % 1996.51 % -204.15 % -242.28 % -200.1 %
GRTX's Overall Ranking # 18 # 19 # 3719 # 3868 # 3248
Seq. Investment Change TTM -24.31 % -0.69 % -32.46 % -37.02 % -31.44 %
Seq. Net Income Change TTM -0.01 % - - - -
Net Income (TTM) in Millions 64 64 -7 -11 -15

GRTX Company Profile >> Back to GRTX Roi Comparisons >> See Annual GRTX Return On Investment



Return On Investment GRTX's Ranking
Within: No.
Industry # 0
Sector # 0
Overall # 18

Return On Investment Statistics
High Average Low
2358.2 %
51.84 %
-242.28 %
(Mar 31 2026)   (Jun 30 2025)







Financial Statements
Galera Therapeutics Inc's I. Quarter Investments $ 1 Millions GRTX's Balance sheet
Galera Therapeutics Inc's I. Quarter Income $ -1 Millions Quarterly GRTX's Income Statement
GRTX's Income by Division See GRTX's Income by Division


GRTX Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 4 4 21 31 70
Y / Y Investment Growth -2.19 % -80.82 % -30.9 % -56.44 % 0.35 %
Net Income in Millions 64 -19 -59 -62 -81
Y / Y Net Income Growth - - - - -
Annual Return On Investment 1598.49 % -461.06 % -278.9 % -202.96 % -114.43 %


Annual Roi Comment
In the fiscal year 2025 ROI improved to 1598.49 % compared to the prior year, due to net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
GRTX's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for GRTX's Competitors
Subscribers only: Roi for Galera Therapeutics Inc's Suppliers
Subscribers only: Return On Investment for GRTX's Customers

Other Ratios
GRTX's Roa GRTX's Inventory Turnover Ratio GRTX's Growth Rates GRTX's Dividend Statistics
GRTX's Profitability Ratios GRTX's Asset Turnover Ratio GRTX's Dividend Growth
GRTX's Roe GRTX's Valuation Ratios GRTX's Financial Strength Ratios GRTX's Dividend Payout Ratio



Companies with similar Return On Investment at Mar 31 2026, within Healthcare Sector ROI
Galera Therapeutics Inc   2,637.52 %
Stablecoin Development Corporation  1,098.22 %
Glucotrack Inc   537.70 %

Date modified: 2026-09-26T07:37:49+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.